by David Kent | Aug 22, 2023
As an academic researcher in the blood stem cell field for the last 20 years, I’ve been involved in a large number of interdisciplinary collaborations and, more recently, a series of industry partnerships. There is no doubt in my mind that cell and gene therapy is one...
by Cal Strode | Aug 16, 2023
In a wide-ranging interview with POLITICO reporter Robert King at the Next Generation of Health Care Therapies event, Dr. Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA), discussed cell and gene...
by Stephie Leung | Jul 20, 2023
A few months ago, I summarized seven local cell therapy companies in Canada that caught my attention. Since then, one full quarter of the financial calendar has passed. In the world of biotechnology start-ups, this could mean one more key milestone achieved, a new...
by Peace Chukwu | Jul 6, 2023
Imagine slowly losing control of your body and the muscles necessary to live healthily, until you eventually lose your ability to breathe. This disease is known as Amyotrophic lateral sclerosis, or ALS, and is caused by the degeneration of motor neurons that send...
by Sara M. Nolte | Jun 21, 2023
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy...
Comments